Affinity Asset Advisors, LLC Innate Pharma Sa Put Options Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IPHA
# of Institutions
11Shares Held
160KCall Options Held
0Put Options Held
0-
Exchange Traded Concepts, LLC62.8KShares$117,3460.0% of portfolio
-
Morgan Stanley New York, NY43.5KShares$81,3890.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il24.3KShares$45,3790.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny15.3KShares$28,6590.0% of portfolio
-
Ubs Group Ag9KShares$16,8310.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $149M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...